Search

Search Results
Results 381 - 390 of 406 for Angiogenesis Inhibitors
  • What is Paclitaxel?
    Health - 24 May 2021
    Paclitaxel is a hydrophobic mitotic inhibitor with a powerful anti-cancer effect.
  • Exploring Preclinical Cancer Models
    Life Sciences - 26 Feb 2021
    Researchers have developed a variety of cancer models that allow each aspect of a tumor to be analyzed at the in vitro and in vivo levels.
  • Lung Cancer Pathogenesis
    Health - 27 Jan 2021
    The pathogenesis of lung cancer is initiated either by the activation of oncogenes or the inactivation of tumor suppressor genes.
  • What is Immunochemotherapy?
    Life Sciences - 4 Dec 2019
    In essence, immunochemotherapy refers to the treatment and management of disease by combining immunotherapy with chemotherapy.
  • Researching Angiogenesis in Cancer
    White Paper - 18 Mar 2019
    Known as neovascularization, angiogenesis is the formation of new blood vessels & is a distinguishing feature of cancer; allowing tumor growth & metastasis.
  • Src Mutations and Cancer
    Health - 27 Feb 2019
    In 1911, Francis Peyton Rous made a groundbreaking discovery that certain types of viruses could trigger sarcoma formation in chickens.
  • Undruggable: The Current State of Drugging Cancer Targets
    Life Sciences - 28 Aug 2023
    The term 'undruggable' refers to proteins or targets that are challenging to target with conventional drugs.
  • Oncology Therapy
    Health - 21 Jun 2023
    Cancers are often considered incurable. With advances in diagnostic methods that allow early diagnosis and detection of cancer and advances in therapeutic modalities there are innumerable patients...
  • Targeting myeloid-derived suppressor cells in the tumor microenvironment
    White Paper - 7 Dec 2022
    In this article, Sino Biological discusses targeting myeloid-derived suppressor cells in the tumor microenvironment to improve the efficacy of tumor immunotherapy.
  • Understanding challenges in cancer therapy utilizing mesenchymal stem cells (MSCs)
    White Paper - 20 Jul 2022
    Mesenchymal Stem Cells (MSCs) are emerging as a viable pathway for cancer therapy. This article discusses the challenges in utilizing MSCs for cancer therapy.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback